Geron reported $378K in Ordinary Share Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US USD 32.37B 1.03B
Cti Biopharma CTIC:US USD 127K 13K
Cytokinetics CYTK:US USD 93K 8K
Esperion Therapeutics ESPR:US USD 72K 7K
Exelixis EXEL:US USD 323K 1000
Genmab GEN:DC DKK 66M 0
Macrogenics MGNX:US USD 615K 0
Novartis NOVN:VX USD 878.25M 11.75M
Novavax NVAX:US USD 792K 4K
Pain Therapeutics PTIE:US USD 40K 0
Seattle Genetics SGEN:US USD 185K 1000